MAPT and Alzheimer disease: Individual proteins exhibited even greater reductions, with key AD‐related markers such as SMOC1, MAPT, and GAP43 decreasing by 40% to 50%, and neuroprotective proteins such as VGF and NRN1 decreasing by nearly 30% (Figure 7D,E).